FRENCH ANIMAL HEALTH R&D INVESTMENTS

Projektträger – zwischengeschaltetes Finanzinstitut

VIRBAC SA

Ort

• Frankreich

Beschreibung

Investment to support research and development (R&D) for a robust portfolio of next-generation innovative products, addressing global animal health issues, to support Virbac's organic growth and international expansion. The project will be largely coordinated and implemented at the company's French R&D sites.

Ziele

The project will support the long-term innovation-driven organic growth of the company while enlarging its product portfolio, strengthening its competitive edge and scaling up market share as global player.

Sektor(en)

• Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 77 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 250 million

Umweltaspekte

All project activities are expected to be carried out in existing facilities and laboratories without changing their already authorised scope and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU, as amended. Nevertheless, the Bank's services will review during the project appraisal whether any of the investments requires an EIA, as well as any other environmental details of the project.

Auftragsvergabe

The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having the status of a contracting entity, thus not subject to EU rules on public procurement.

Projektstatus

Unterzeichnet - 25/07/2017